Niskanen E, Champlin R, Oki A, Golde D W, Gale R P, Cline M J
Stem Cells (1981). 1982;2(4):246-52.
Hemopoietic cells from human fetal livers of 9-21 weeks gestation were cultured in semisolid media in vitro and in diffusion chambers implanted in mice. Myeloid colony formation in agar (CFU-C) was detected only in the presence of colony-stimulating factor. Formation of erythroid bursts in vitro was enhanced by addition of erythropoietin or erythroid-potentiating activity derived from a human T cell line (Mo). Fetal liver cells implanted in diffusion chambers gave rise to myeloid (CFU-DG) and occasionally to erythroid colonies. Administration of colony-stimulating factor derived from the T cell line to the host mice did not effect CFU-DG numbers. In contrast, a partially purified preparation containing erythroid-potentiating activity, caused a significant increase in the formation of CFU-DG. Similar stimulation was achieved by pretreatment of the diffusion chamber hosts with cyclophosphamide. None of these manipulations effected erythroid colony formation in diffusion chambers in mice.
对妊娠9至21周的人胎肝造血细胞进行体外半固体培养基培养,并将其植入小鼠体内的扩散盒中。只有在集落刺激因子存在的情况下,才能检测到琼脂中髓系集落的形成(CFU-C)。添加促红细胞生成素或源自人T细胞系(Mo)的红系增强活性可增强体外红系集落的形成。植入扩散盒中的胎肝细胞可产生髓系集落(CFU-DG),偶尔也会产生红系集落。向宿主小鼠施用源自T细胞系的集落刺激因子不会影响CFU-DG的数量。相反,含有红系增强活性的部分纯化制剂可导致CFU-DG形成显著增加。用环磷酰胺预处理扩散盒宿主也可获得类似的刺激效果。这些操作均未影响小鼠扩散盒中红系集落的形成。